Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MorphoSys AG - American Depositary Shares (NQ:MOR)

18.96 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MorphoSys AG - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Dow Surges 100 Points; Cogent Biosciences Shares Plunge
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.28% to 36,349.22 while the NASDAQ fell 0.36% to 14,352.34. The S&P... 
Via Benzinga
Topics Stocks
Cigna Calls Off Humana Merger, Joins Macy's, Snap And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow Jones futures trading almost flat on Monday. 
Via Benzinga
Topics Stocks
MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study
From MorphoSys AG
Via Business Wire
Sprinklr Reports Downbeat Earnings, Joins Chewy, GameStop And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures traded mixed this morning, with the Dow Jones futures falling around 70 points on Thursday. Shares of Sprinklr, Inc. (NYSE: CXM) shares fell sharply in pre-market trading following... 
Via Benzinga
Topics Stocks
Expert Ratings for MorphoSys
 
Via Benzinga
Recap: MorphoSys Q3 Earnings
 
Via Benzinga
Dell Reports Mixed Q3 Results, Joins Marvell Technology, Super Micro Computer And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures traded higher this morning, with the Dow Jones futures gaining more than 80 points on Friday. 
Via Benzinga
Topics Stocks
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday. 
Via Benzinga
Topics Stocks
Zscaler Posts Q1 Results, Joins argenx, Cool Company And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded mixed this morning, with the Dow Jones futures gaining around 15 points on Tuesday. 
Via Benzinga
Topics Stocks
MorphoSys's Earnings Outlook
 
Via Benzinga
Invitation to MorphoSys' Third Quarter and First Nine Months 2023 Financial Results Conference Call on November 16, 2023
Via ACCESSWIRE
DLocal Posts Weak Results, Joins HP, Autodesk And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded higher this morning, with the Dow Jones futures gaining around 40 points on Wednesday. 
Via Benzinga
Topics Stocks
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Origin Materials Layoffs 2023: What to Know About the Latest ORGN Job Cuts
Origin Materials layoffs have the company cutting 30% of its workforce as it plans to switch focus with a major restructuring. 
Via InvestorPlace
Topics Workforce
Why Is Cancer Focused MorphoSys Stock Trading Lower Today?
MorphoSys AG (NASDAQ: MOR) released topline results from the Phase 3 MANIFEST-2 study investigating pelabresib, an investigational BET inhibitor, in combination with the JAK inhibitor ruxolitinib... 
Via Benzinga
FSR Stock Alert: Fisker Receives Non-Compliance Notice From NYSE
Fisker stock is falling on Tuesday as FSR investors react to a non-compliance notice and the resignation of its new CAO. 
Via InvestorPlace
Why Is MorphoSys (MOR) Stock Down 20% Today?
MorphoSys stock is falling on Tuesday with heavy trading of MOR shares despite the company posting positive data from a Phase 3 study. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Shares of Symbotic Inc. (NASDAQ: SYM) surged in pre-market trading after the company reported better-than-expected fourth-quarter sales results. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start Tuesday trading with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning! 
Via InvestorPlace
AVITA Medical Cuts Revenue Forecast, Joins iQIYI, Trip.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded mostly lower this morning, with the Dow Jones futures falling around 50 points on Tuesday. 
Via Benzinga
Topics Stocks
Ad hoc: MorphoSys' Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction
Via ACCESSWIRE
MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction
From MorphoSys AG
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
From MorphoSys AG
Via Business Wire
MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting
Via ACCESSWIRE
MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
Via ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2023
 
Via Benzinga
Palo Alto Networks To Rally Over 21%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.